2-168906660-G-A

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_021176.3(G6PC2):​c.441-4G>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000554 in 1,470,228 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.0026 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 1 hom. )

Consequence

G6PC2
NM_021176.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00002811
2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.126
Variant links:
Genes affected
G6PC2 (HGNC:28906): (glucose-6-phosphatase catalytic subunit 2) This gene encodes an enzyme belonging to the glucose-6-phosphatase catalytic subunit family. These enzymes are part of a multicomponent integral membrane system that catalyzes the hydrolysis of glucose-6-phosphate, the terminal step in gluconeogenic and glycogenolytic pathways, allowing the release of glucose into the bloodstream. The family member encoded by this gene is found in pancreatic islets and does not exhibit phosphohydrolase activity, but it is a major target of cell-mediated autoimmunity in diabetes. Several alternatively spliced transcript variants of this gene have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
SPC25 (HGNC:24031): (SPC25 component of NDC80 kinetochore complex) This gene encodes a protein that may be involved in kinetochore-microtubule interaction and spindle checkpoint activity. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-168906660-G-A is Benign according to our data. Variant chr2-168906660-G-A is described in ClinVar as [Benign]. Clinvar id is 3039044.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
G6PC2NM_021176.3 linkuse as main transcriptc.441-4G>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000375363.8 NP_066999.1
G6PC2NM_001081686.2 linkuse as main transcriptc.441-908G>A intron_variant NP_001075155.1
G6PC2XM_011511564.4 linkuse as main transcriptc.329-908G>A intron_variant XP_011509866.1
G6PC2XM_011511565.4 linkuse as main transcriptc.93-4G>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant XP_011509867.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
G6PC2ENST00000375363.8 linkuse as main transcriptc.441-4G>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_021176.3 ENSP00000364512 P1Q9NQR9-1

Frequencies

GnomAD3 genomes
AF:
0.00258
AC:
393
AN:
152118
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00908
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.000724
AC:
182
AN:
251274
Hom.:
0
AF XY:
0.000515
AC XY:
70
AN XY:
135824
show subpopulations
Gnomad AFR exome
AF:
0.00972
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000489
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000320
AC:
422
AN:
1317992
Hom.:
1
Cov.:
21
AF XY:
0.000268
AC XY:
178
AN XY:
663770
show subpopulations
Gnomad4 AFR exome
AF:
0.0106
Gnomad4 AMR exome
AF:
0.000202
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000640
Gnomad4 SAS exome
AF:
0.0000960
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000245
Gnomad4 OTH exome
AF:
0.000558
GnomAD4 genome
AF:
0.00258
AC:
393
AN:
152236
Hom.:
1
Cov.:
32
AF XY:
0.00243
AC XY:
181
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.00905
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00153
Hom.:
0
Bravo
AF:
0.00286
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

G6PC2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 28, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.16
DANN
Benign
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000028
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs181737385; hg19: chr2-169763170; API